171
Participants
Start Date
September 30, 2013
Primary Completion Date
September 30, 2016
Study Completion Date
September 30, 2016
Viaskin Peanut 250 mcg
Subjects epicutaneously administered for 24 hours every 24 hours with a patch containing 250 mcg peanut proteins as whole peanut extract
Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Centre Hospitalier Universitaire de Bordeaux, Hôpital Pellegrin, Bordeaux
Cincinnati Children's Hospital Medical Center, Cincinnati
Hôpitaux De Brabois, Vandœuvre-lès-Nancy
Hôpital Saint Vincent de Paul, Lille
Children's Memorial Hospital, Chicago
Nouvel Hôpital Civil, Strasbourg
Children's Medical Center Dallas, Dallas
Hôpital Necker, Paris
University of California, Rady Childrens Hospital, San Diego
Stanford University School of Medicine, Stanford
ASTHMA, Inc., Seattle
Massachusetts General Hospital, Boston
Boston Childrens' Hospital, Boston
Cheema Research Inc., Mississauga
Ottawa Allergy Asthma Research Institute, Ottawa
Gordon Sussman Clinical Research, Toronto
Centre de Recherche Appliquée en Asthme et Allergie de Québec, Sainte-Foy
GCS des hôpitaux pédiatriques, Nice
Erasmus MC, Rotterdam
UMC Utrecht, Utrecht
Lead Sponsor
DBV Technologies
INDUSTRY